CTIM-20. PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Yasmeen Rauf; David Peereboom; Jaleh Fallah; Cathy Schilero; Pamela Lackner; Glen Stevens; Manmeet Ahluwalia

doi:10.1093/NEUONC/NOAA215.154

CTIM-20. PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Yasmeen Rauf, David Peereboom, Jaleh Fallah, Cathy Schilero, Pamela Lackner, Glen Stevens, Manmeet Ahluwalia

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
DOIs	https://doi.org/10.1093/NEUONC/NOAA215.154
State	Published - Nov 9 2020
Event	Neuro-oncology - Duration: Nov 9 2020 → …

Conference

Conference	Neuro-oncology
Period	11/9/20 → …

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1093/NEUONC/NOAA215.154License: Unspecified

Cite this

@conference{6217fb7eddad46c4b8f814b8866d6e56,

title = "CTIM-20. PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA",

author = "Yasmeen Rauf and David Peereboom and Jaleh Fallah and Cathy Schilero and Pamela Lackner and Glen Stevens and Manmeet Ahluwalia",

note = "AbstractBACKGROUND. Glioblastoma is a devastating disease that is notoriously resistant to current therapies, leading to dismal patient outcomes and a median su; Neuro-oncology ; Conference date: 09-11-2020",

year = "2020",

month = nov,

day = "9",

doi = "10.1093/NEUONC/NOAA215.154",

language = "American English",

}

TY - CONF

T1 - CTIM-20. PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

AU - Rauf, Yasmeen

AU - Peereboom, David

AU - Fallah, Jaleh

AU - Schilero, Cathy

AU - Lackner, Pamela

AU - Stevens, Glen

AU - Ahluwalia, Manmeet

N1 - AbstractBACKGROUND. Glioblastoma is a devastating disease that is notoriously resistant to current therapies, leading to dismal patient outcomes and a median su

PY - 2020/11/9

Y1 - 2020/11/9

UR - https://academic.oup.com/neuro-oncology/article-abstract/22/Supplement_2/ii37/5960582

U2 - 10.1093/NEUONC/NOAA215.154

DO - 10.1093/NEUONC/NOAA215.154

M3 - Presentation

T2 - Neuro-oncology

Y2 - 9 November 2020

ER -

CTIM-20. PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Conference

Disciplines

Access to Document

Other files and links

Cite this